Testing a smallpox/mpox vaccine for safety and immune response
Part of Infections clinical trials.
This trial tests an MVA-based vaccine (MVA-SIBP) to see if it is safe and creates a good immune response against smallpox and mpox. It's for healthy people in certain age groups who have not had these vaccines or infections before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 2 and 45 years old.
- You are in good general health.
- You have never received a smallpox or mpox vaccine, and never had monkeypox, cowpox, or vaccinia virus infection.
- You can attend all study visits and follow safety rules.
- If you are an adult able to get pregnant, you must use effective birth control and not be pregnant or breastfeeding.
- You live in the study area and do not plan to move during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who get a booster dose of the MVA-BN smallpox vaccine. It checks how the body responds and helps researchers understand the vaccine's effects.
This study tests people for VMPX to learn more about the condition and to understand how it affects the body. You can join if you are willing to be tested and can give permission.
This trial tests a new monkeypox vaccine to see if it is safe and helps the body build protection. It may be an option for adults who were born before 1980 and received a smallpox vaccine, or who meet other health criteria.
This trial tests a new monkeypox vaccine to see if it's safe and works. It's for healthy adults who haven't had monkeypox or smallpox before.
This study examines how your body's immune system remembers and responds to monkeypox infection. Researchers will analyze blood samples to understand the types of immunity you develop, which may help improve future treatments and vaccines.
This study looks at the medical and lab changes in people with suspected or likely monkeypox, and in adults who may be eligible for a monkeypox vaccine. Your participation helps researchers understand how infection and vaccination affect the body and how to improve care.
Hear when a new Monkeypox (Mpox) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.